The total revenue generated by the magnetoencephalography market was valued at USD 275 million in 2022, and it will power at a rate of 5.60% in the years to come to reach USD 426 million by 2030, as stated by a market research institution, P&S Intelligence.
 |
| To learn more about this report: https://bit.ly/3NWM0H2 |
The growth of the industry can be mainly credited to the increasing tech developments happening, the increasing prevalence of neurological ailments, the growing focus on the use of non-invasive procedures, and the growing elderly population.
These scanners show their efficiency in the epilepsy detection, dementia, brain tumors, sclerosis, pain perception, and many more neuro problems. Likewise, without misrepresentation, it is possible that neuromagnetic impulses can pass through the scalp and skull.
North America dominated the magnetoencephalography market, and the trend will continue in the years to come, with USD 149 million in 2030. This is because of the high acceptance of novel and cutting-edge technologies and high income in the region.
Furthermore, the next-gen sequencing technology delivers quicker and more precise results, as a result of which it is put to use in Canada and the U.S.
U.S. is the leader and it will grow with a rate of 5.7% in the years to come. This is credited to the robust healthcare infra, the existence of numerous key players, a surge in the product launch count, high expenditure on healthcare projects, and high investments in R&D activities in mental health field, in the nation.
Due to the increasing progressions in technologies all over the world, increasing cases of neurogenerative disorders, the demand for the magnetoencephalography processes will continue to grow in the years to come.
